It looks like your message might be empty. Could you clarify your question or provide more details about what you need help with? I'm here to assist! .

China SXT Pharmaceuticals surged 20.65% intraday, as the company announced the issuance of 90 million new shares in June 2025 to raise funds. The company, which specializes in the research, development, production, and sales of traditional Chinese medicine products (including advanced, refined, and standard TCMP), reported in its 2025 annual filing submitted on July 31 that its client base spans 57 pharmaceutical companies, 14 chain pharmacies, and 16 hospitals across five provinces.